Diagnosing Parkinson Disease
- PMID: 27495197
- DOI: 10.1212/CON.0000000000000345
Diagnosing Parkinson Disease
Abstract
Purpose of review: While establishing the diagnosis of Parkinson disease (PD) can be straightforward, it can be challenging in some patients, even for the experienced neurologist. The misdiagnosis rate ranges from 10% to 20% or greater depending on clinician experience.
Recent findings: Despite promise in the search for a biomarker that can establish the presence of PD and act as a marker of its progression, the diagnosis of PD continues to be based on clinical examination. Core criteria, exclusion criteria, and supportive criteria have been developed to aid the clinician in establishing the diagnosis. Nonmotor symptoms of PD are usually present at the time of diagnosis, may precede motor symptoms, and should be specifically sought during evaluation. Ancillary testing can be appropriate, but its indications and utility must be clearly understood.
Summary: The diagnosis of PD requires the recognition of the core features of PD and the differentiation of its clinical presentation from other entities with similar and potentially overlapping symptoms. A careful history and examination guided by clinical diagnostic criteria will usually establish the diagnosis of PD or uncover red flags for the possibilities of other diagnoses. Appropriate selection and interpretation of ancillary testing is critical to avoid misdiagnosis and unnecessary tests.
Similar articles
-
[New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria].Brain Nerve. 2018 Feb;70(2):139-146. doi: 10.11477/mf.1416200966. Brain Nerve. 2018. PMID: 29433115 Review. Japanese.
-
MDS clinical diagnostic criteria for Parkinson's disease.Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424. Mov Disord. 2015. PMID: 26474316 Review.
-
Diagnosis and the premotor phase of Parkinson disease.Neurology. 2009 Feb 17;72(7 Suppl):S12-20. doi: 10.1212/WNL.0b013e318198db11. Neurology. 2009. PMID: 19221308 Review.
-
Parkinson's disease: chameleons and mimics.Pract Neurol. 2015 Feb;15(1):14-25. doi: 10.1136/practneurol-2014-000849. Epub 2014 Sep 24. Pract Neurol. 2015. PMID: 25253895 Review.
-
Initial motor symptoms of Parkinson disease.Neurologist. 2011 Nov;17(6 Suppl 1):S18-20. doi: 10.1097/NRL.0b013e31823966b4. Neurologist. 2011. PMID: 22045320 Review.
Cited by
-
Parkinson's Disease Gene Biomarkers Screened by the LASSO and SVM Algorithms.Brain Sci. 2023 Jan 20;13(2):175. doi: 10.3390/brainsci13020175. Brain Sci. 2023. PMID: 36831718 Free PMC article.
-
Clinical biomarkers for Lewy body diseases.Cell Biosci. 2023 Nov 14;13(1):209. doi: 10.1186/s13578-023-01152-x. Cell Biosci. 2023. PMID: 37964309 Free PMC article. Review.
-
Brain-Biomarker Changes in Body Fluids of Patients with Parkinson's Disease.Int J Mol Sci. 2023 Jun 30;24(13):10932. doi: 10.3390/ijms241310932. Int J Mol Sci. 2023. PMID: 37446110 Free PMC article. Review.
-
High-Affinity Detection of Alpha-Synuclein by Aptamer-Gold Conjugates on an Amine-Modified Dielectric Surface.J Anal Methods Chem. 2019 Nov 30;2019:6526850. doi: 10.1155/2019/6526850. eCollection 2019. J Anal Methods Chem. 2019. PMID: 31886023 Free PMC article.
-
The Phenomenology of Parkinson's Disease.Semin Neurol. 2017 Apr;37(2):109-117. doi: 10.1055/s-0037-1601869. Epub 2017 May 16. Semin Neurol. 2017. PMID: 28511251 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials